Ultragenyx Pharmaceutical (RARE) has an average rating of overweight and mean price target of $33.95, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Krishna Institute of Medical Sciences (NSE:KIMS, BOM:543308) has an average rating of buy and mean price target of 873.40 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Deep Yellow (ASX:DYL) has an average rating of overweight and mean price target of AU$2.01, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Charoen Pokphand Indonesia (IDX:CPIN) has an average rating of overweight and mean price target of 4,243.33 rupiah, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)